CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $13.5M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
BL
1
BCWM LLC
Overland Park,
Kansas
|
$4.62M |
2 |
2
Citigroup
New York
|
$0 |
3 |
APA
3
American Portfolios Advisors
Holbrook,
New York
|
$287K |
4 |
CA
4
Calton & Associates
Tampa,
Florida
|
$0 |